. . . . . . . . . . . . . . . "875"^^ . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . . . . . "Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B"@en . . . "Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B"@en . . "klinisch onderzoek"@nl . . . . . . . "2015-11-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . . "NCT01940471" . "ensayu cl\u00EDnicu"@ast . . . "2013-08-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B"@en . . . . . . . "18"^^ . . . . "clinical trial"@en . . . . . . . . . . . . . "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . . . . . . . . . "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B"@en . . .